- |||||||||| Alecsat (cytotoxic lymphocyte-based cancer vaccine) / CytoVac
New P1/2 trial, Metastases: ImmunoBreast - A Phase Ib Study (clinicaltrials.gov) - Oct 29, 2020 P1/2, N=20, Recruiting,
- |||||||||| Alecsat (cytotoxic lymphocyte-based cancer vaccine) / CytoVac, Avastin (bevacizumab) / Roche
Enrollment change, Trial termination, Trial primary completion date, Tumor cell: Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan (clinicaltrials.gov) - Jun 17, 2015 P2, N=25, Terminated, Recruiting --> Active, not recruiting | Trial completion date: Jan 2022 --> Jun 2021 | Trial primary completion date: Jan 2020 --> Jun 2020 N=175 --> 25 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Jun 2015; Substantial design modifications required.
|